Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitable

Final draft guidance

Final appraisal document (PDF 208 KB)

Committee papers (PDF 5.65 MB)

Final scope (PDF 194 KB)

Final scope (PDF 55 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 210 KB)

Final stakeholder list (PDF 177 KB)

Consultation document (PDF 361 KB)

Committee papers (PDF 16.21 MB)

Committee slides (PDF 8.96 MB)

Final appraisal document (PDF 386 KB)

Committee papers (PDF 1.5 MB)